Products - Chronic kidney disease | Topic | NICE

Showing 6 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Pegcetacoplan for treating complement 3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis in people 12 years and over [ID6489]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
7 April 2026
Expected publication date:
18 June 2026
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sirolimus-eluting collagen implant for creating vascular access for haemodialysis in end-stage kidney disease [TSID9147]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Iptacopan for treating primary IgA nephropathy [ID6640]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Iptacopan for treating complement 3 glomerulopathy in people 12 to 18 years [ID6738]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC